Skip to content
  • HOME
  • Technology
    • ARCEDI Technology
    • Patents
    • Publications
  • Products
    • ARCEDI Products
    • EVITA Test Complete
    • EVITA Test Gender
    • Pipeline
  • About
    • About ARCEDI
    • Executive management
    • Board of directors
    • Investor
    • Contact
  • NEWS
Menu
  • HOME
  • Technology
    • ARCEDI Technology
    • Patents
    • Publications
  • Products
    • ARCEDI Products
    • EVITA Test Complete
    • EVITA Test Gender
    • Pipeline
  • About
    • About ARCEDI
    • Executive management
    • Board of directors
    • Investor
    • Contact
  • NEWS
Search
Close

Press photos

  • -
  • April 6, 2021
  • Niewijk G.

Download press photos below

PrevPreviousCell-based non-invasive prenatal testing for monogenic disorders: confirmation of unaffected fetuses following preimplantation genetic testing
NextCase stories (in Danish): Vores oplevelse med EVITA TESTNext

ADRESSE

Main office 
Tabletvej 1 | DK-7100 Vejle | Denmark

Aarhus office
INCUBA | Palle Juul-Jensens Boulevard 82 |
DK-8200 Aarhus N | Denmark

CONTACT

If you have any questions regarding ARCEDI,
you are welcome to contact us

CVR NR.

CVR nr.: 25577922

Follow us

LinkedIn

©2021 ARCEDI Biotech ApS. All rights reserved. ARCEDI® is a registred trademark.

Empowered by design-people